vs
Side-by-side financial comparison of Quest Diagnostics (DGX) and Willis Towers Watson (WTW). Click either name above to swap in a different company.
Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $2.9B, roughly 1.0× Willis Towers Watson). Willis Towers Watson runs the higher net margin — 25.5% vs 9.7%, a 15.8% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs -3.5%). Over the past eight quarters, Willis Towers Watson's revenue compounded faster (12.0% CAGR vs 9.9%).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Willis Towers Watson plc is a British-American multinational advisory, broking and solutions company. Its operations span commercial insurance brokerage and risk advisory, employee benefits and rewards consulting, retirement and actuarial services, and investment advice for pension funds and institutional investors.
DGX vs WTW — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.9B | $2.9B |
| Net Profit | $281.0M | $735.0M |
| Gross Margin | — | — |
| Operating Margin | 15.4% | 35.3% |
| Net Margin | 9.7% | 25.5% |
| Revenue YoY | 9.2% | -3.5% |
| Net Profit YoY | 12.0% | -41.0% |
| EPS (diluted) | $2.24 | $7.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.8B | $2.9B | ||
| Q3 25 | $2.8B | $2.2B | ||
| Q2 25 | $2.8B | $2.2B | ||
| Q1 25 | $2.7B | $2.2B | ||
| Q4 24 | $2.6B | $3.0B | ||
| Q3 24 | $2.5B | $2.2B | ||
| Q2 24 | $2.4B | $2.2B |
| Q1 26 | $281.0M | — | ||
| Q4 25 | $245.0M | $735.0M | ||
| Q3 25 | $245.0M | $304.0M | ||
| Q2 25 | $282.0M | $331.0M | ||
| Q1 25 | $220.0M | $235.0M | ||
| Q4 24 | $222.0M | $1.2B | ||
| Q3 24 | $226.0M | $-1.7B | ||
| Q2 24 | $229.0M | $141.0M |
| Q1 26 | — | — | ||
| Q4 25 | 32.4% | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 32.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 32.6% | — | ||
| Q2 24 | 33.5% | — |
| Q1 26 | 15.4% | — | ||
| Q4 25 | 13.8% | 35.3% | ||
| Q3 25 | 13.7% | 18.7% | ||
| Q2 25 | 15.9% | 16.6% | ||
| Q1 25 | 13.0% | 19.8% | ||
| Q4 24 | 13.8% | 30.2% | ||
| Q3 24 | 13.3% | -34.2% | ||
| Q2 24 | 14.8% | 9.6% |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 8.7% | 25.5% | ||
| Q3 25 | 8.7% | 13.6% | ||
| Q2 25 | 10.2% | 14.9% | ||
| Q1 25 | 8.3% | 10.8% | ||
| Q4 24 | 8.5% | 41.7% | ||
| Q3 24 | 9.1% | -74.8% | ||
| Q2 24 | 9.6% | 6.4% |
| Q1 26 | $2.24 | — | ||
| Q4 25 | $2.18 | $7.50 | ||
| Q3 25 | $2.16 | $3.11 | ||
| Q2 25 | $2.47 | $3.32 | ||
| Q1 25 | $1.94 | $2.33 | ||
| Q4 24 | $1.95 | $12.29 | ||
| Q3 24 | $1.99 | $-16.44 | ||
| Q2 24 | $2.03 | $1.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $393.0M | $3.2B |
| Total DebtLower is stronger | $5.7B | $9.7B |
| Stockholders' EquityBook value | $7.7B | $8.0B |
| Total Assets | $16.7B | $29.5B |
| Debt / EquityLower = less leverage | 0.74× | 1.21× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $393.0M | — | ||
| Q4 25 | $420.0M | $3.2B | ||
| Q3 25 | $432.0M | $1.9B | ||
| Q2 25 | $319.0M | $2.0B | ||
| Q1 25 | $188.0M | $1.5B | ||
| Q4 24 | $549.0M | $1.9B | ||
| Q3 24 | $764.0M | $1.4B | ||
| Q2 24 | $271.0M | $1.2B |
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.2B | $9.7B | ||
| Q3 25 | $5.2B | — | ||
| Q2 25 | $5.2B | — | ||
| Q1 25 | $5.9B | — | ||
| Q4 24 | $5.6B | $8.6B | ||
| Q3 24 | $5.6B | — | ||
| Q2 24 | $3.8B | — |
| Q1 26 | $7.7B | — | ||
| Q4 25 | $7.2B | $8.0B | ||
| Q3 25 | $7.3B | $7.7B | ||
| Q2 25 | $7.2B | $8.1B | ||
| Q1 25 | $6.9B | $8.1B | ||
| Q4 24 | $6.8B | $7.9B | ||
| Q3 24 | $6.8B | $7.5B | ||
| Q2 24 | $6.6B | $9.3B |
| Q1 26 | $16.7B | — | ||
| Q4 25 | $16.2B | $29.5B | ||
| Q3 25 | $16.2B | $27.4B | ||
| Q2 25 | $16.0B | $28.5B | ||
| Q1 25 | $15.8B | $28.1B | ||
| Q4 24 | $16.2B | $27.7B | ||
| Q3 24 | $16.1B | $27.2B | ||
| Q2 24 | $13.9B | $29.6B |
| Q1 26 | 0.74× | — | ||
| Q4 25 | 0.72× | 1.21× | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 0.83× | 1.08× | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.58× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.0M | $771.0M |
| Free Cash FlowOCF − Capex | — | $708.0M |
| FCF MarginFCF / Revenue | — | 24.6% |
| Capex IntensityCapex / Revenue | 3.9% | 2.2% |
| Cash ConversionOCF / Net Profit | 0.99× | 1.05× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $278.0M | — | ||
| Q4 25 | $465.0M | $771.0M | ||
| Q3 25 | $563.0M | $678.0M | ||
| Q2 25 | $544.0M | $361.0M | ||
| Q1 25 | $314.0M | $-35.0M | ||
| Q4 24 | $464.0M | $599.0M | ||
| Q3 24 | $356.0M | $482.0M | ||
| Q2 24 | $360.0M | $407.0M |
| Q1 26 | — | — | ||
| Q4 25 | $307.0M | $708.0M | ||
| Q3 25 | $419.0M | $621.0M | ||
| Q2 25 | $436.0M | $303.0M | ||
| Q1 25 | $197.0M | $-86.0M | ||
| Q4 24 | $341.0M | $543.0M | ||
| Q3 24 | $250.0M | $419.0M | ||
| Q2 24 | $268.0M | $341.0M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 24.6% | ||
| Q3 25 | 14.9% | 27.7% | ||
| Q2 25 | 15.8% | 13.7% | ||
| Q1 25 | 7.4% | -3.9% | ||
| Q4 24 | 13.0% | 18.2% | ||
| Q3 24 | 10.0% | 18.7% | ||
| Q2 24 | 11.2% | 15.4% |
| Q1 26 | 3.9% | — | ||
| Q4 25 | 5.6% | 2.2% | ||
| Q3 25 | 5.1% | 2.5% | ||
| Q2 25 | 3.9% | 2.6% | ||
| Q1 25 | 4.4% | 2.3% | ||
| Q4 24 | 4.7% | 1.9% | ||
| Q3 24 | 4.3% | 2.8% | ||
| Q2 24 | 3.8% | 3.0% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.90× | 1.05× | ||
| Q3 25 | 2.30× | 2.23× | ||
| Q2 25 | 1.93× | 1.09× | ||
| Q1 25 | 1.43× | -0.15× | ||
| Q4 24 | 2.09× | 0.48× | ||
| Q3 24 | 1.58× | — | ||
| Q2 24 | 1.57× | 2.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DGX
Segment breakdown not available.
WTW
| Health Wealth And Career | $1.7B | 58% |
| GB | $566.0M | 20% |
| Broking | $465.0M | 16% |
| Other | $113.0M | 4% |
| December Thirty One Two Thousand And Twenty Four | $67.0M | 2% |
| IE | $38.0M | 1% |
